Harter P, Mouret-Reynier MA, Pignata S, Cropet C, et al. Efficacy of maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed, advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial. Gynecol Oncol 2021 Dec 21. pii: S0090-8258(21)01673.
PMID: 34952708